SEC Form 4 · accession 0001235802-16-000326
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean Carney
Director
Period of report
Dec 1, 2016
Accepted (ET)
Dec 2, 2016 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF1 | Dec 1, 2016 | M | 6,448 | $18.04 | A | 45,450 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF1 | Dec 1, 2016 | M | 7,538 | $19.45 | A | 52,988 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF1 | Dec 1, 2016 | M | 6,034 | $21.66 | A | 59,022 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF1 | Dec 1, 2016 | M | 5,509 | $20.62 | A | 64,531 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF1 | Dec 1, 2016 | S | 25,529 | $22.7932 | D | 39,002 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF1 | Dec 1, 2016 | S | 29,219 | $22.847 | D | 9,783 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $18.04 | Dec 1, 2016 | M | 6,448 | D | — | Aug 10, 2022 | Ordinary Shares | 6,448 | 0 | D |
| Stock Option (right to buy)F4 | $19.45 | Dec 1, 2016 | M | 7,538 | D | — | Aug 9, 2023 | Ordinary Shares | 7,538 | 0 | D |
| Stock Option (right to buy)F4 | $21.66 | Dec 1, 2016 | M | 6,034 | D | — | Aug 12, 2024 | Ordinary Shares | 6,034 | 0 | D |
| Stock Option (right to buy)F5 | $20.62 | Dec 1, 2016 | M | 5,509 | D | — | Oct 13, 2025 | Ordinary Shares | 5,509 | 5,509 | D |
Explanation of responses
- F1Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.6850 to $22.9150 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.7900 to $22.9500 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4This option has fully vested.
- F5This option vests in two annual installments, on the one-year and two-year anniversaries of October 13, 2015.